Summit Corporation Share Price (SUMM)

139.50 -8.00 (-5.42%) delayed: 10:31PM BST
Bid price 137.00 Open price 147.50
Ask price 142.00 Prev close 139.50
High price 142.90 Spread 3.52%
Low price 135.21 Volume 51,568

Register now for FREE live Summit Corporation share prices, Summit Corporation stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Summit Corporation Level 2 Data, indepth research tools and investor commentary for Summit Corporation (SUMM) and other London Stock Exchange equities.

Summit Corporation Share Price Chart

Advanced Charts >>

Register now for FREE Summit Corporation share price charts

Summit Corporation Share Price Information

Name Summit Corporation Epic SUMM
Sector Pharmaceuticals & Biotechnology ISIN GB00BN40HZ01
Activites Summit Therapeutics plc (formerly Summit Corporation plc, formerly VASTox plc) is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit's goal is to become a fully integrated biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Index n/a

Summit Corporation Key Numbers

Latest Share Price (p) 139.50 Net Gearing (%) -2.43
Market Capitalisation (£m) 89.95 Gross Gearing (%) 28.19
Shares in issue (m) 60.98 Debt Ratio 0.00
P/E Ratio -98.99 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.39
Dividend Yield (%) 0.00 Price to book value 18.90
Dividend cover (x) 0.00 ROCE -1.46
Earning per share (p) -1.49 EPS Growth (%) 0.00
52 week high / low 185.00 / 101.25 DPS Growth (%) n/a

Summit Corporation Director Deals

Dec.Date Type Director Pos No. of Shares
30/07/2014 BUY Glyn Edwards CEO 30,000
26/07/2013 PLAC Glyn Edwards CEO 600,000
26/07/2013 PLAC Dr Frank Armstrong CH 50,000
26/07/2013 PLAC Barry Price NED 500,000
26/07/2013 PLAC Jim Mellon RES 20,000,000

More Summit Corporation Director Deals >>

Summit Corporation Company News

12:00 07/04/2015

Summit to Present at Needham & Company's Annual...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Summit to Present at Needham & Company's Annual Healthcare Conference Summit Therapeutics plc ("Summit" or the "Company") SUMMIT TO...

07:02 27/03/2015

Summit Therapeutics plc : Holding(s) in Company

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Summit Therapeutics plc : Holding(s) in Company For filings with the FCA include the annex   For filings with issuer exclude...

More Summit Corporation Company News >>

Register now for FREE Summit Corporation company news

Summit Corporation Share Price Discussions

1 months ago

Summit Corporation PLC (SUMM)

http://www.summitplc.com/ Summit is an Oxford, UK based drug discovery company developing novel drug candidates to treat areas of high unmet medical need. Our strategy has evolved to focus on the development of two high-value clinical-stage programmes that target the fatal genetic disease...

more than 1 year ago

Summer Bonanza is upon us.......... (SUMM)

OK folks it's mid March and spring is upon us. Time to start looking ahead, the mkts have had a bit of a setback, is this the healthy correction that's been spoken about for so long or is it a buying opportunity on the road to new highs? Who knows, not me for sure, if I did I'd tell ya'll...

Register now for FREE Summit Corporation share price discussions